{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T13:31:18Z","timestamp":1795095078350,"version":"4.10.2"},"reference-count":24,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.1080\/21645515.2025.2463194","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T21:46:51Z","timestamp":1740433611000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["Safety, tolerability, and immunogenicity of pentavalent meningococcal MenABCWY vaccine in healthy infants: A phase 2b randomized clinical trial"],"prefix":"10.1080","volume":"21","author":[{"given":"Federico","family":"Martinon-Torres","sequence":"first","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria de Santiago (IDIS)","place":["Santiago de Compostela, Spain"]},{"name":"Instituto de Salud Carlos III","place":["Madrid, Spain"]},{"name":"Hospital Cl\u00ednico Universitario and University of Santiago de Compostela (USC)","place":["Santiago de Compostela, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Lamberth","sequence":"additional","affiliation":[{"name":"Pfizer Inc","place":["Collegeville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvina","family":"Natalini Martinez","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria HM","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Salamanca de la Cueva","sequence":"additional","affiliation":[{"name":"Grupo IHP (Instituto Hispalense de Pediatr\u00eda)","place":["Sevilla, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lefteris","family":"Zolotas","sequence":"additional","affiliation":[{"name":"Pfizer Ltd","place":["Marlow, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Islamiat","family":"Oladipupo","sequence":"additional","affiliation":[{"name":"Pfizer Inc","place":["Pearl River, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Maguire","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria HM","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Trammel","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria HM","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"O\u2019Neill","sequence":"additional","affiliation":[{"name":"Pfizer Inc","place":["Pearl River, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Liberator","sequence":"additional","affiliation":[{"name":"Pfizer Inc","place":["Pearl River, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Peyrani","sequence":"additional","affiliation":[{"name":"Vaccines and Antivirals, Pfizer Inc","place":["Collegeville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Jodar","sequence":"additional","affiliation":[{"name":"Vaccines and Antivirals, Pfizer Inc","place":["Collegeville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Gruber","sequence":"additional","affiliation":[{"name":"Pfizer Inc","place":["Pearl River, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annaliesa S.","family":"Anderson","sequence":"additional","affiliation":[{"name":"Pfizer Inc","place":["Pearl River, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Beeslaar","sequence":"additional","affiliation":[{"name":"Pfizer Ltd","place":["Marlow, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,2,24]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268823000328"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200105033441807"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.04.020"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.05.079"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.03.011"},{"key":"e_1_3_6_7_1","unstructured":"PENBRAYATM. (Meningococcal Groups A B C W and Y Vaccine) suspension for intramuscular injection. Full Prescribing Information. [2023 Dec]. https:\/\/labeling.pfizer.com\/ShowLabeling.aspx?id=19937."},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00191-3"},{"key":"e_1_3_6_9_1","unstructured":"World Health Organization. Meningococcal vaccines: WHO position paper on the use of multivalent meningococcal conjugate vaccines in countries of the African meningitis belt. 2024 Jan. accessed 2024 Sep 16] https:\/\/www.who.int\/publications\/i\/item\/who-wer9901-02-1-10."},{"key":"e_1_3_6_10_1","unstructured":"World Health Organization. In world first Nigeria introduces new 5-in-1 vaccine against meningitis. [accessed 2024 Sep 16]. https:\/\/www.who.int\/news\/item\/12-04-2024-in-world-first\u2013nigeria-introduces-new-5-in-1-vaccine-against-meningitis."},{"key":"e_1_3_6_11_1","unstructured":"European Medicines Agency. Annex I: Summary of product characteristics (Nimenrix). [accessed 2018 Mar 5]. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/002226\/WC500127663.pdf."},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2020.1745070"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.09.077"},{"key":"e_1_3_6_14_1","unstructured":"European Medicines Agency. Annex I: Summary of product characteristics (Trumenba). [accessed 2018 Nov 7]. https:\/\/www.ema.europa.eu\/documents\/product-information\/trumenba-epar-product-information_en.pdf."},{"key":"e_1_3_6_15_1","unstructured":"Trumenba\u00ae (meningococcal group B vaccine). Full prescribing information. [accessed 2023 June 23]. https:\/\/www.fda.gov\/media\/89936\/download."},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(22)00424-8"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.07.049"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.Cd012655"},{"key":"e_1_3_6_19_1","volume-title":"Summary of Product Characteristics","author":"Bexsero (meningococcal group B vaccine [rDNA, component, adsorbed","year":"2023","unstructured":"Bexsero (meningococcal group B vaccine [rDNA, component, adsorbed]). Summary of Product Characteristics. Sovicille, Italy: GSK Vaccines; 2023."},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2245705"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2022.2064850"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200022030-00005"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14073"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2019-316811"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31829063cd"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2025.2463194","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/21645515.2025.2463194","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2025.2463194","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:27:37Z","timestamp":1786033657000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2025.2463194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,24]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1080\/21645515.2025.2463194"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2025.2463194","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-09-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-17","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2463194"}}